Survivorship Study of Cancer Patients Who Received Cranial Radiation Therapy

Inclusion Criteria

• •1. Cancer survivors who received cranial irradiation including, but not limited to, primary brain tumor, brain metastases, lung cancer receiving prophylactic brain irradiation, long-term survivors of pediatric cancers
• •2. Initial radiation must have been completed more than 6 months prior to enrollment. Acceptable radiation therapies include fractionated partial brain irradiation, whole brain irradiation, or stereotactic radiosurgery (for any modality at least a total cumulative dose of 20 Gy) of at least 20 Gy
• •3. Age ≥ 18 years at the time of entry into the study
• •4. Karnofsky performance score (KPS) ≥ 70 or Eastern Cooperative Oncology Group (ECOG) grade ≤ 2
• •5. No imaging evidence of disease progression within 4 months of enrollment
• •6. Life expectancy \> 6 months per treating neuro-oncology providers
• •7. Access to a smartphone, tablet, or computer with capability to utilize the mobile symptom-tracking application
• •8. Subject must be fluent in English